2 form the product aminoacyl-tRNA (aa-tRNA), which enters the ribosome according to the tRNA anticodon. Although the ribosome machinery is highly efficient, thanks to protein factors that ensure rapid capture of aa-tRNA to support protein synthesis, recent work has shown that some aa-tRNAs can escape capture and instead participate in peptide synthesis outside the ribosome. For example, cyclodipeptide synthases (CDPSs) hijack aa-tRNAs to make cyclodipeptides 1 (Fig.1a) , but how they accomplish this task was unknown. One page xx of this In the proposed mechanism (Fig.1a) , the Ser88 hydroxyl performs nucleophilic attack on the carbonyl ester of the first aa 1 -tRNA 1 , leading to the formation of the covalent enzyme-aa 1 intermediate and the release of the deacylated tRNA 1 . Structural data suggest that the active site should rearrange to accommodate the entry of a second aa 2 -tRNA 2 , upon which the α-amino group of the tRNA-bound aa 2 would attack the enzyme-bound aa 1 to generate the tRNA-bound dipeptide aa 1 -aa 2 . Following a second nucleophilic attack by the α-amino group of aa 1 on the carbonyl ester of aa 2 is the formation of the product cyclodipeptide and the release of tRNA 2 .
Mutational analysis implicates the involvement of a general base in the active site (the CDPSsignature residue E233 of Rv2275) that would accelerate proton abstraction of the α-amino group of aa 2 -tRNA 2 to promote nucleophilic attack and would also assist in the protonation of the deacylated tRNA 2 to facilitate product release.
The proposed mechanism highlights two remarkable features of making cyclodipeptides on tRNA. One is the sequential use of aa-tRNAs as the donors of already activated amino acids, thus affording CDPSs with a small structure (without the amino-acid activation domain) to catalyze a complex reaction. The second is the covalent trapping of the first amino acid on CDPSs while arranging the second aa-tRNA for the chemistry step. This covalent strategy may be necessary to compete for the cellular pools of aa-tRNAs, which after synthesis on aaRSs are typically captured by elongation factor EF-Tu for rapid delivery to the ribosome. However, even with the first amino acid stabilized, the competition for the second aa-tRNA is formidably more challenging because the covalent mechanism is no longer invoked. Intriguingly, their structural homology to class Ic aaRSs suggests that CDPSs should bind aa-tRNA favorably, because class I aaRSs generally exhibit preferentially high affinities to the aa-tRNA product 7 , and because the dimeric Ic structure has been suggested to serve as a barrier to prevent direct release of aa-tRNA to EF-Tu 7 . These considerations provide a useful framework to appreciate the unexpected structural homology.
The current structure should be a springboard to jump start additional structural work on the CDPS enzymes, preferably in complexes with bound substrates. Such structures will help to address unresolved questions, pertaining to their selectivity of aa-tRNA, the determinants for the
